This site is intended for healthcare professionals
News

CHMP recommends extended approval for Dupixent in severe atopic dermatitis in children.- Sanofi

Read time: 1 mins
Last updated:18th Oct 2020
Published:17th Oct 2020
Condition: Atopic Dermatitis (Eczema)
Type: drug
Register free for full access to medthority.com